DRI Healthcare Trust reports Q3 2026 results, acquires Juvmo royalty rights for $316M

DRI Healthcare Trust reported Q3 2026 results with total income of $46.9 million and normalized total cash receipts of $47.5 million. It acquired royalty participation rights in Juvmo (tavapadon) for $316 million, its largest transaction to date, and recorded a $14.6 million non-cash impairment on its Zejula royalty asset.

Detected & updated continuously · Source: Nebula